Sao Paulo medical journal = Revista paulista de medicina · 2026
Potentially inappropriate medication use among older outpatients-prevalence and contributing factors: a retrospective study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bozkurt Meris Esra, Ozturk Ercument
Аннотация
BACKGROUND: Adverse outcomes associated with potentially inappropriate medication (PIM) use are prevalent among older adults.
OBJECTIVES: This study aimed to determine the frequency of PIM use older outpatients and assess its association with chronic comorbidities and geriatric syndromes using the screening tool of older persons' prescriptions (STOPP) and screening tool to alert to right treatment (START) version 3 criteria.
DESIGN AND SETTING: This retrospective study included patients aged 65 years or older who attended geriatric outpatient clinics between January and June 2024.
METHODS: PIM use was evaluated using the STOPP/START version 3 criteria. Polypharmacy was defined as the use of five or more medications.
RESULTS: Among the 107 patients (median age, 77 years; range, 65-91), 71% (n = 76) used PIM, with a median of two PIMs per patient (range, 0-6). PIM use was significantly more prevalent among patients with polypharmacy (odds ratio [OR] = 3.986; 95% CI: 1.493-10.639; p = 0.006). Analyses based on the STOPP criteria also revealed significant associations of PIM use with dementia (OR = 13.240; 95% CI: 1.504-116.529; p = 0.02), polypharmacy (OR = 4.352; 95% CI: 1.476-12.827; p = 0.008), and a history of falls (OR = 3.131; 95% CI: 1.017-9.634; p = 0.047).
CONCLUSION: Polypharmacy was significantly associated with greater odds of PIM use among older adults. Based on the STOPP version 3 criteria, dementia and a history of falls were also associated with increased PIM use in this population.
OBJECTIVES: This study aimed to determine the frequency of PIM use older outpatients and assess its association with chronic comorbidities and geriatric syndromes using the screening tool of older persons' prescriptions (STOPP) and screening tool to alert to right treatment (START) version 3 criteria.
DESIGN AND SETTING: This retrospective study included patients aged 65 years or older who attended geriatric outpatient clinics between January and June 2024.
METHODS: PIM use was evaluated using the STOPP/START version 3 criteria. Polypharmacy was defined as the use of five or more medications.
RESULTS: Among the 107 patients (median age, 77 years; range, 65-91), 71% (n = 76) used PIM, with a median of two PIMs per patient (range, 0-6). PIM use was significantly more prevalent among patients with polypharmacy (odds ratio [OR] = 3.986; 95% CI: 1.493-10.639; p = 0.006). Analyses based on the STOPP criteria also revealed significant associations of PIM use with dementia (OR = 13.240; 95% CI: 1.504-116.529; p = 0.02), polypharmacy (OR = 4.352; 95% CI: 1.476-12.827; p = 0.008), and a history of falls (OR = 3.131; 95% CI: 1.017-9.634; p = 0.047).
CONCLUSION: Polypharmacy was significantly associated with greater odds of PIM use among older adults. Based on the STOPP version 3 criteria, dementia and a history of falls were also associated with increased PIM use in this population.